Pluristem Therapeutics to present at the Tel-Aviv Stock Exchange
Pluristem Therapeutics Inc., a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient cell therapy products for a variety of disorders, announced today that it will be presenting the Company's development program at 9 am on Wednesday, April 22, 2009 at the Stock Exchange in Tel Aviv, Israel.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, commented today on recent trading activity in its common stock.